Economic evaluations of dialysis treatment modalities.
OBJECTIVE
The purpose of this paper is to review published economic evaluations of dialysis treatment modalities, including hemodialysis (HD) and peritoneal dialysis (PD).


METHODS
A systematic literature review was conducted in both PubMed and EMBASE for the years 1996-2006. Articles were included if they were original research articles comparing PD and HD or comparing subtypes of PD and HD.


RESULTS
Twenty-five articles were included in the formal literature review. The majority of articles were cost evaluations, rather than full economic evaluations of both costs and outcomes. The results show that, in developed nations, HD is generally more expensive than PD to the payer. In developing and emerging economies, mainly due to inexpensive labor and high imported equipment and solution costs, PD is not infrequently perceived to be more expensive than HD. However, the costs of dialysis differ by region and additional research is needed particularly in developing economies.


CONCLUSIONS
HD is a more expensive dialysis modality in developed regions of the world. Research in the developing world is too limited to draw definitive conclusions.
Just
Paul Michael
PM
Baxter Healthcare Corporation, 1620 Waukegan Road, MPGR-A2E, McGaw Park, IL 60085, USA. paul_just@baxter.com
Riella
Miguel Carlos
MC
Tschosik
Elizabeth Ann
EA
Noe
Leslie Lyle
LL
Bhattacharyya
Samir Kumar
SK
de Charro
Frank
F
D006801:Humans; D017059:Models, Econometric; D010530:Peritoneal Dialysis / Q000191:economics*; D006435:Renal Dialysis / Q000191:economics*